In November 2026, Munich Re reported a third quarter life and health reinsurance technical result of EUR 493 million, up from EUR 314 million a year earlier. The company published the segment detail on 12 November for the quarter ended 30 September. It attributed the performance to strong new business and favourable biometric experience, particularly mortality. The segment net result rose to EUR 340 million from EUR 286 million.